Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer

NuklearMedizin

Volumn 46, Issue 5, 2007, Pages 161-168

  Eschmann, Susanne Martina ^a,b   Pfannenberg, A C ^a   Rieger, A ^a   Aschoff, P ^a   Muller M ^a   Paulsen, F ^a   Anastasiadis, A ^a   Claussen, C D ^a   Bares, R ^a   Schlemmer, H P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MARIENHOSPITAL STUTTGART   (Germany)

Author keywords

11C choline PET CT; MRI; Prostate cancer; Staging

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT;

ADULT; AGED; BONE METASTASIS; BRAIN METASTASIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING; ARTICLE; BONE TUMOR; METASTASIS; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING;

BONE NEOPLASMS; CARBON RADIOISOTOPES; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35349004770     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1160/nukmed-0075     Document Type: Review

References (13)

1. Antoch G, Vogt FM, Freudenberg LS et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncolgy. JAMA 2003; 290: 3199-3206.
2. Garnick MB, Fair WR. Combating prostate cancer. Sci Am 1998; 279: 74-83.
3. Ghanem N, Uhl M, Brink I et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005; 55: 41-55.
4. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998; 39: 990-995.
5. Harisinghani MG, Barentsz J, Hahn PF et al. Non-invasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-2499.
6. 11C-Cholme PET. J Nucl Med 2003; 44: 331-335.
7. Kotzerke J, Prang J, Neumaier B et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 2000; 27: 1415-1419.
8. 11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin 2003; 42: 25-30.
9. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. J Urol 2006;176:954-960.
10. 11C-choline PET/CT. J Nucl Med 2006; 47: 1249-1254.
11. Schäfer J, Schlemmer HP. Total-body MR-imaging in oncology. Eur J Radiol 2006; 16: 2000-2015.
12. Schlemmer HP, Schäfer J, Pfannenberg C et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system. Invest Radiol 2005; 40: 64-71.
13. 11C-choline PET and MRI imaging combined with proton MR spectroscopy. Eur J Nucl Med 2005; 32: 742-748.